Method of treating cancer comprising administering 2 - amino - 4 - methyl - ethyl - 4 - 6 - (1h pyrazole - 5 - il) pirido [2,3-d] pyrimidine 7 (8h) - one and N - ((S) - (2,3-dihydroxypropyl) - 3 - (2 - fluoro - 4 - Iodine - phenylamino) isonicotinamide; Pharmaceutical composition; use a Combination to treat cancer as cancer Lung, Triple Negative Breast Cancer, among others.
Methods of treating patients with cancer are provided, wherein the methods comprise administering to the patient an effective amount of a MEK inhibitor and an effective amount of a PI3K inhibitor. Compositions in which the MEK and PI3K inhibitors are combined also are described.MÉTODO DE TRATAMIENTO DEL CÁNCER QUE COMPRENDE ADMINISTRAR 2-AMINO-8-ETIL-4-METIL-6-(1H-PIRAZOL-5-IL)PIRIDO[2,3-D]PIRIMIDIN-7(8H)-ONA Y N-((S)-2,3-DIHIDROXIPROPIL)-3-(2-FLUORO-4-YODO-FENILAMINO)ISONICOTINAMIDA; COMPOSICION FARMACEUTICA; USO DE UNA COMBINACION PARA TRATAR CANCER TAL COMO CANCER DE PULMON, CANCER DE MAMA TRIPLE NEGATIVO, ENTRE OTROS.